IBDEI1CV ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24011,1,4,0)
 ;;=4^905.0
 ;;^UTILITY(U,$J,358.3,24011,2)
 ;;=^275214
 ;;^UTILITY(U,$J,358.3,24012,0)
 ;;=907.0^^130^1456^3
 ;;^UTILITY(U,$J,358.3,24012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24012,1,3,0)
 ;;=3^Late Effect w/o Skull Fx
 ;;^UTILITY(U,$J,358.3,24012,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,24012,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,24013,0)
 ;;=V15.52^^130^1456^1
 ;;^UTILITY(U,$J,358.3,24013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24013,1,3,0)
 ;;=3^Personal Hx of TBI
 ;;^UTILITY(U,$J,358.3,24013,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,24013,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,24014,0)
 ;;=V15.59^^130^1457^1
 ;;^UTILITY(U,$J,358.3,24014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24014,1,3,0)
 ;;=3^Personal Hx of Injury
 ;;^UTILITY(U,$J,358.3,24014,1,4,0)
 ;;=4^V15.59
 ;;^UTILITY(U,$J,358.3,24014,2)
 ;;=^336787
 ;;^UTILITY(U,$J,358.3,24015,0)
 ;;=413.9^^130^1458^1
 ;;^UTILITY(U,$J,358.3,24015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24015,1,3,0)
 ;;=3^Angina Pectoris NEC/NOS
 ;;^UTILITY(U,$J,358.3,24015,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,24015,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,24016,0)
 ;;=716.90^^130^1458^2
 ;;^UTILITY(U,$J,358.3,24016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24016,1,3,0)
 ;;=3^Arthropathy NOS
 ;;^UTILITY(U,$J,358.3,24016,1,4,0)
 ;;=4^716.90
 ;;^UTILITY(U,$J,358.3,24016,2)
 ;;=^66343
 ;;^UTILITY(U,$J,358.3,24017,0)
 ;;=428.0^^130^1458^3
 ;;^UTILITY(U,$J,358.3,24017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24017,1,3,0)
 ;;=3^CHF,Unspec
 ;;^UTILITY(U,$J,358.3,24017,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,24017,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,24018,0)
 ;;=585.9^^130^1458^4
 ;;^UTILITY(U,$J,358.3,24018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24018,1,3,0)
 ;;=3^Chr Kidney Disease NOS
 ;;^UTILITY(U,$J,358.3,24018,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,24018,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,24019,0)
 ;;=585.1^^130^1458^5
 ;;^UTILITY(U,$J,358.3,24019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24019,1,3,0)
 ;;=3^Chr Kidney Disease,Stage I
 ;;^UTILITY(U,$J,358.3,24019,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,24019,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,24020,0)
 ;;=585.2^^130^1458^6
 ;;^UTILITY(U,$J,358.3,24020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24020,1,3,0)
 ;;=3^Chr Kidney Disease,Stage II
 ;;^UTILITY(U,$J,358.3,24020,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,24020,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,24021,0)
 ;;=585.3^^130^1458^7
 ;;^UTILITY(U,$J,358.3,24021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24021,1,3,0)
 ;;=3^Chr Kidney Disease,Stage III
 ;;^UTILITY(U,$J,358.3,24021,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,24021,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,24022,0)
 ;;=585.4^^130^1458^8
 ;;^UTILITY(U,$J,358.3,24022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24022,1,3,0)
 ;;=3^Chr Kidney Disease,Stage IV
 ;;^UTILITY(U,$J,358.3,24022,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,24022,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,24023,0)
 ;;=585.5^^130^1458^9
 ;;^UTILITY(U,$J,358.3,24023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24023,1,3,0)
 ;;=3^Chr Kidney Disease,Stage V
 ;;^UTILITY(U,$J,358.3,24023,1,4,0)
 ;;=4^585.5
 ;;^UTILITY(U,$J,358.3,24023,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,24024,0)
 ;;=585.6^^130^1458^11
 ;;^UTILITY(U,$J,358.3,24024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24024,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,24024,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,24024,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,24025,0)
 ;;=401.9^^130^1458^12
 ;;^UTILITY(U,$J,358.3,24025,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1CV
